Yale New Haven Health System has ousted its CEO, Chris O’Connor, amidst financial struggles and a failed bid to acquire hospitals from Prospect Medical Holdings. O’Connor, a New Haven native and longtime employee, was well-liked and respected in the healthcare sector.
Financial Pressures
The health system’s financial recovery from COVID has been sluggish, with operating losses in recent years. A failed deal to acquire three Connecticut hospitals cost the system $45 million. State Comptroller Sean Scanlon expressed surprise at O’Connor’s departure, praising him as a skilled leader.
Yale New Haven Health’s financial performance has lagged behind its competitor, Hartford HealthCare. The system’s current president, Pamela Sutton-Wallace, has been appointed acting CEO. A national search for a permanent replacement will be conducted in the coming months.
Challenges Ahead
The next CEO will face challenges in balancing the interests of Yale New Haven Health System with those of Yale University. State Sen. Saud Anwar, a physician and co-chair of the legislature’s Public Health Committee, acknowledged the difficulties of leading a healthcare system during these times.
Original reporting: New Haven Independent — read the source article.
